Investing Profile

Charles Homcy

InvestorVC
Partner at Third Rock Ventures
thirdrockventures.com/people/...San Francisco, California
Photo of Charles Homcy, Partner at Third Rock Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
7
$770M
CompanyStageDateRound SizeTotal Raised
Marea Therapeutics
Series BJun 2024$190M
Series AJun 2024$65M
$260M
Co-investors: Jeffrey Tong (Third Rock Ventures), Maha Katabi (Sofinnova Investments), Aaron Royston (venBio), Chris Garabedian (Perceptive Advisors)
Ambys Medicines
Series ADec 2021$47M
$110M
Co-investors: Jeffrey Tong (Third Rock Ventures)
Maze Therapeutics
Series AFeb 2019$190M
$800M
Co-investors: Jonathan Lim (SignalFire), Brendan Bulik-Sullivan (GV (Google Ventures)), Anthony Philippakis (GV (Google Ventures)), Jonathan Lim (ARCH Venture Partners), Andy Tran (Matrix Capital Management Company, L.P.), James W. Brush (Frazier Healthcare Partners)
CytomX Therapeutics
Series CJan 2015$20M
$61M
Co-investors: Tim Shannon (Canaan Partners), Neil Exter (Third Rock Ventures)
MyoKardia
Series UnknownAug 2014$10M
$10M
Topica Pharmaceuticals
Series BOct 2011$27M
$27M